meritain health glp 1 coverage Doctors call Ozempic a miracle drug. Medicaid officials aren't so sure Insurer strategies to control costs

Hims & Hers' weight loss business continues to be a major focus for the company, and that segment is on pace to bring in $725 million in revenue in 2025, Yemi Okupe, Hims & Hers' chief financial officer, said during the Q3 call with investors in early November

When retatrutide activates GLP-1 receptors in the brain, it reduces appetite and increases feelings of fullness

GLP-1 agonists enhance insulin secretion from pancreatic beta cells only when blood glucose levels are elevated, a mechanism termed "glucose-dependent insulinotropic action." This physiological approach reduces the risk of hypoglycemia compared with sulfonylureas or exogenous insulin, though the risk increases when GLP-1 agents are combined with insulin or sulfonylureas, potentially requiring dose adjustments of these medications

Overdose of benzodiazepines in combination with other CNS depressants (including alcohol) may be fatal and should be closely monitored

A genetically supported drug repurposing pipeline for diabetes treatment using electronic health records

This can offer a good balance between convenience and effectiveness